Pharm-Olam's response to COVID-19 from CEO Rob Davie, PhD. Read Here

Request a Proposal  

Pharm-Olam Blog

Pharm-Olam Insights Blog

Pharm-Olam is a global CRO dedicated to helping you create a healthier world through the development of life-changing treatments. Here on our blog we will share our insights from recent studies, to interviews with industry leaders, investigators and patients.

Blog Feature

Pharm-Olam Insights | Oncology-Hematology Disease

By: Ibett Romero
March 19th, 2020

Pharm-Olam is a mid-sized, global CRO that provides clinical research solutions for rare diseases, oncology, hematology, autoimmune conditions, allergies, and infectious diseases. Our organization was hired to support a Phase I, first-in-human study of a programmed cell death receptor (PD-1) inhibitor monoclonal antibody (mAb) drug treatment for solid tumor malignancies. The research is in its final stages. Pharm-Olam is proud to have supported this critical research, the patients and the sponsor involved.